Malignant progression of SEGA-imitating fibrous meningioma in a child carrying a germline CHEK2 mutation
Pathobiology · 2026
DOI: 10.1159/000550591 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathobiology, 2026. Verfasst von Bartosz Szmyd und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland. Hauptthemen laut MEDLINE: Astrocytoma, Meningioma, Germ-Line Mutation, Checkpoint Kinase 2.
Abstract (Originalsprache)
Background
The subependymal giant cell astrocytoma (SEGA) predominantly occurs in patients with tuberous sclerosis. Here, we present an unusual aggressive transformation of SEGA-imitating fibrous meningioma in a child carrying a germline CHEK2 mutation Methods: This case study was conducted at a tertiary pediatric oncology center in accordance with current diagnostic and therapeutic standards. Tumor classification followed WHO CNS5 criteria and was complemented by genome-wide DNA methylation profiling. Comprehensive molecular workup included germline and somatic whole-exome sequencing, copy-number analysis, and RNA-sequencing; Results: An 8.5-year-old girl presented with an intraventricular tumor initially diagnosed as SEGA based on imaging and partial resection histology. Treatment with an mTOR inhibitor led to four years of stability before rapid progression and death due to postoperative brain edema. Re-examination of both specimens revealed transformation into an aggressive anaplastic meningioma, while the initial lesion was reclassified as fibrous meningioma. Whole-exome and microarray analyses excluded germline TSC1/TSC2 defects but identified a pathogenic germline CHEK2 variant (c.1466del, p.Asn489ThrfsTer23). Somatic alterations involving NF1, and TP53 were found in the primary tumor.
Conclusions
Constitutional CHEK2 mutations combined with somatic NF1 defect may have promoted the malignant progression of SEGA-imitating fibrous meningioma and its favorable initial response to mTOR inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.
- Department of Neurosurgery and Neuro-Oncology, Medical University of Lodz, Lodz, Poland.
- Department of Pathology, Chair of Oncology, Medical University of Lodz, Lodz, Poland.
- Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland, agata.pastorczak@umed.lodz.pl.
- Department of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz, Poland, agata.pastorczak@umed.lodz.pl.
- Laboratory of Translational Oncology, Intercollegiate Faculty of Biotechnology of University of Gdansk and Medical University of Gdansk, Gdansk, Poland.
Zitieren
APA
Szmyd, B., Braun, M., Pastorczak, A., Jaskólski, D. J., Madzio, J., Miarka-Walczyk, K., Urbańska, Z., Grajkowska, W., Trubicka, J., Adamek, D., Barańska, D., Młynarski, W., & Trelińska, J. (2026). Malignant progression of SEGA-imitating fibrous meningioma in a child carrying a germline CHEK2 mutation. Pathobiology. https://doi.org/10.1159/000550591
Vancouver
Szmyd B, Braun M, Pastorczak A, Jaskólski DJ, Madzio J, Miarka-Walczyk K, et al. Malignant progression of SEGA-imitating fibrous meningioma in a child carrying a germline CHEK2 mutation. Pathobiology. 2026. doi:10.1159/000550591
BibTeX
@article{Szmyd2026,
author = {Szmyd, Bartosz and Braun, Marcin and Pastorczak, Agata and Jaskólski, Dariusz Jan and Madzio, Joanna and Miarka-Walczyk, Karolina and Urbańska, Zuzanna and Grajkowska, Wiesława and Trubicka, Joanna and Adamek, Dariusz and Barańska, Dobromiła and Młynarski, Wojciech and Trelińska, Joanna},
title = {Malignant progression of SEGA-imitating fibrous meningioma in a child carrying a germline CHEK2 mutation},
journal = {Pathobiology},
year = {2026},
doi = {10.1159/000550591}
}
EUVIMED